AdvanSix Inc. (ASIX) 股票分析

公司概述

AdvanSix Inc. operates as an integrated chemistry company that specializes in the manufacture and sale of polymer resins across the United States and international markets. The firm's core product offering includes Nylon 6, a synthetic polymer resin utilized for the production of fibers, filaments, engineered plastics, and films, serving diverse industrial applications. This enterprise functions within the Basic Materials sector, specifically under the Chemicals industry, positioning it as a key supplier of essential raw materials for downstream manufacturing processes. As of the latest data, the company maintains a market capitalization of $626.95M, generates $1.52B in annual revenue, and employs 1,410 staff members. These valuation and revenue figures indicate that AdvanSix is a mid-cap entity with a significant operational footprint, though its market cap suggests it trades at a smaller scale compared to large-cap chemical peers, reflecting specific niche dominance or cyclical market conditions rather than broad diversification.

财务健康

The company reported $1.52B in revenue over the trailing twelve months, with net income of $49.29M and an EBITDA of $139.93M. The substantial gap between the $1.52B revenue and $49.29M net income reveals a cost structure where operating expenses, including cost of goods sold and administrative costs, absorb a significant portion of top-line growth before reaching the bottom line. Free cash flow stands at -$19,318,876, indicating a current outflow of cash from operations after capital expenditures, which suggests limited immediate financial flexibility for aggressive expansion or debt repayment without external financing. Margin analysis shows a gross margin of 10.8%, an operating margin of -0.3%, and a profit margin of 3.2%; the negative operating margin specifically highlights that operating expenses exceeded gross profit, while the positive profit margin implies that non-operating income or other comprehensive income helped restore profitability to the bottom line. On the balance sheet, total cash of $19.77M is significantly lower than total debt of $382.69M, and the debt-to-equity ratio of 46.94 indicates a highly leveraged capital structure where debt obligations are nearly 47 times equity. The current ratio of 1.13 suggests that the company holds slightly more current assets than current liabilities, indicating a tight but technically sufficient short-term liquidity position to meet immediate obligations. Return on equity is 6.2% and return on assets is 2.3%, metrics that reveal management effectiveness is moderate, generating relatively low returns on the capital base deployed, which is consistent with capital-intensive chemical manufacturing sectors facing cyclical headwinds.

估值评估

The trailing P/E ratio is 12.96, while the forward P/E is 8.21, implying that the market expects earnings to grow significantly in the future to justify the current multiple contraction, as the forward multiple is substantially lower than the trailing one. The price-to-book ratio stands at 0.77, indicating that the stock trades at a discount to its book value, which suggests the market is pricing in potential asset impairments or cyclical downturns rather than applying a premium for growth. Alternative valuation metrics include a price-to-sales ratio of 0.41 and an EV/EBITDA of 7.07, figures that suggest the company is valued conservatively relative to its sales and cash-flow-generating capabilities, often seen in cyclical basic materials during periods of lower demand. The 52-week high is $25.94 and the 52-week low is $14.10; assuming a current market context near the lower end of this historical range, the stock is trading at a significant discount relative to its recent peak, reflecting market caution. The beta value is 1.43, meaning the stock exhibits higher price volatility relative to the broader market, moving approximately 43% more than the market index during periods of fluctuation.

Growth & Income

Revenue growth year-over-year is 9.4%, while earnings growth is marked as N/A due to lack of comparable prior period data or negative prior earnings, making a direct comparison of growth rates impossible. Consequently, the absence of a reported earnings growth rate prevents a definitive assessment of whether earnings are growing faster or slower than revenue, though the positive revenue growth indicates expanding sales volume. As a dividend payer, the company offers a dividend yield of 2.7% with a payout ratio of 35.6%, a level that appears sustainable given the current profit margin and cash generation, provided that operating conditions stabilize to cover the negative free cash flow. The overall growth and income profile presents a scenario of expanding revenue without confirmed earnings acceleration, supported by a moderate dividend yield, which targets income-focused investors while acknowledging the challenges of maintaining profitability in a capital-intensive, leveraged environment.